Publication date: Available online 12 November 2026 Source: Cell Reports Medicine Author(s): Mengmeng Wang, Shuangwei Liu, Lei Xu, Weiteng Cao, Xinyue Wang, Yubo Wang, Yanshuo Cheng, Ning Liu, Ziqi Huang, Kun Zhang, Ranlu Liu, Lan Ma, Cheng Yang, Guang Yang
XPO5 regulates ferroptosis via MITF-ACSL4 signaling to drive CRPC progression and serves as a druggable target. // Chinese General Practice Journal. – URL: https://www.sciencedirect.com/science/article/pii/S2666379126005860?dgcid=rss_sd_all
XPO5 regulates ferroptosis via MITF-ACSL4 signaling to drive CRPC progression and serves as a druggable target. Chinese General Practice Journal. https://www.sciencedirect.com/science/article/pii/S2666379126005860?dgcid=rss_sd_all
“XPO5 regulates ferroptosis via MITF-ACSL4 signaling to drive CRPC progression and serves as a druggable target.” Chinese General Practice Journal.
@article{article4676,
title = {XPO5 regulates ferroptosis via MITF-ACSL4 signaling to drive CRPC progression and serves as a druggable target},
journal = {Chinese General Practice Journal},
url = {https://www.sciencedirect.com/science/article/pii/S2666379126005860?dgcid=rss_sd_all}
}
Publication date: December 2026 Source: Journal of Electromyography and Kinesiology, Volume 91 Author(s): Pierre Garnault, Yannick Aoustin, Vigen Arakelian
Publication date: December 2026 Source: Journal of Electromyography and Kinesiology, Volume 91 Author(s): Mihailo Petrovic, Ann-Katrin Stensdotter, Helena Grip
Publication date: December 2026 Source: Journal of Electromyography and Kinesiology, Volume 91 Author(s): Michael Croskery, Victor Chan, Ryan B. Graham